ClinicalTrials.gg
Enrolling by invitationNCT07012499Updated Jun 10, 2025

QOL and Mental Health Using APD With Remote Monitoring System

An interventional study of Automated peritoneal dialysis with Sharesource device and APD without sharesource in Quality of Life and Mental Health Wellness 1, sponsored by Wonju Severance Christian Hospital. Enrolling by invitation at 1 site in Korea, Republic of. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-10.

Sponsored by Wonju Severance Christian Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as enrolling by invitation.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Although peritoneal dialysis (PD) is a representative renal replacement therapy along with hemodialysis, number of PD patients decreases every year. Among the various contributing factors for such trends, the essential issue that the patients should perform dialytic therapy by themselves is thought to be critical for the patients to avoid choosing PD as primary dialytic therapy. In particular, unlike hemodialysis, the patients with PD have troubles in getting timely medical advice in their daily life, although continuous advice are essential for maintaining therapy. Thus, remote monitoring and control system is believed to be useful in PD therapy.

Automated PD (APD) is a good option because of its convenience and improved accessibility. So, in Korea, although the rate of incident PD patients was decreased, the proportion of APD were rapidly increased (3.7% in 2001 vs. 39% in 2018, Korean Society of Nephrology (KSN) data) In the COVID-19 pandemic, the investigators should improve Remote therapy monitoring (RTM). Technologies that collect medical information and transmit it to health care providers for patient management, have the potential to improve the patients' outcomes without visiting hospital receiving automated peritoneal dialysis (APD) at home. However, there are only a few retrospective studies and no prospective study about remote patients monitoring programs in APD. Remote medical service is currently illegal in South Korea. However, recently the Korean government has approved remote medical service in only a few areas of Gangwon province, including Wonju city, which belongs to our institution.

Thus, the investigators aim to use such a benefit to investigate the 'Quality of Life (QOL)' in Korean patients undergoing APD. The investigators plan to compare the various clinical indexes, including mainly QOL, mental health focusing depression, and volume-nutritional status between the patients with previous classic APD and APD combined by the SharesourceTM system (Baxter Co.).

02

Conditions studied

  • Quality of Life
  • Mental Health Wellness 1

Keywords

  • remote control
  • Automated peritoneal dialysis
03

In context

Lead sponsor

Wonju Severance Christian Hospital is the lead sponsor of 43 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • More than 18 years old
  • ESRD patients on APD(≥1 month)
  • Consent to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Patients who plan to receive kidney transplantation within 1 year
  • Patients with co-morbidities: cardiovascular disease(myocardial infarction, heart failure, arrhythmia), cancer, psychiatric diseases, liver cirrhosis
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    APD with Sharesource

    Patients received APD with Sharesource system

    Device: Automated peritoneal dialysis with Sharesource device

  • Placebo comparator
    APD without Sharesource

    Patients received APD without sharesource

    Device: APD without sharesource

Interventions

  • DeviceAutomated peritoneal dialysis with Sharesource device

    Patients receive APD with an FMC device that contains sharesource software which can communicate with the medical team.

  • DeviceAPD without sharesource

    Patients received APD with Same machine but this patients dose not using sharesource software

06

What researchers measure

Primary outcomes

  1. changes of quality of life KDQOL-36

    Time frame: 6, 12 months

  2. changes of quality of life PHQ-9

    Time frame: 6, 12 months

  3. changes of quality of life BDI

    Time frame: 6, 12 months

  4. changes of quality of life CESD

    Time frame: 6, 12 months

Secondary outcomes

  1. change volume status

    Overhydration (measured by bioimpedance device)

    Time frame: 6, 12 months

  2. change nutrition status

    GNRI (geriatric nutrition risk index), Handgrip strength test (kg)

    Time frame: 6, 12 months

  3. dialysis adequacy

    KT/V

    Time frame: 6,12 months

  4. Questionnaire form.

    change of PD perscription, personalized prescription changes, hospital admission, ER admission, unplanned hospital visit, exchanges over telephone

    Time frame: 6,12 months

  5. adverse events

    peritonitis, mechanical comlications

    Time frame: 12 months

  6. Body mass index (BMI: kg/m2)

    Time frame: 6 months, 12 months

Other outcomes

  1. Total time or PD

    Total time of PD

    Time frame: 90 Days

  2. Medical coast of treatment

    Medical coast

    Time frame: 12 month

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Dec 2025; primary completion for Dec 2025, 0 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 24, 2025
First posted
Jun 10, 2025
StartEst.
Dec 1, 2025
Primary completionEst.
Dec 30, 2025
CompletionEst.
Dec 31, 2025
Last update
Jun 10, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 10, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07012499
Lead sponsor
Wonju Severance Christian Hospital
Responsible party
Sponsor
First posted
Jun 10, 2025
Start date
Dec 1, 2025 (estimated)
Primary completion
Dec 30, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Jun 10, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion